World Health Organization. (2019). International Classification of Diseases, 10th Revision (ICD-10). Geneva: WHO Press.
[2]
American Heart Association. (2021). Guidelines for the Management of Valvular Heart Disease. Circulation, 143(5), e123-e156.
[3]
European Society of Cardiology. (2021). ESC Guidelines for the Management of Valvular Heart Disease. European Heart Journal, 42(37), 3739-3846.
[4]
Nishimura, R. A., et al. (2020). ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology, 75(6), e57-e200.
[5]
Baumgartner, H., et al. (2017). ESC/EACTS Guidelines for the Management of Valvular Heart Disease. European Journal of Cardio-Thoracic Surgery, 52(4), 616-664.
[6]
Manning, W. J. (2020). Asymptomatic Aortic Stenosis in the Elderly: A Clinical Review. JAMA, 324(12), 1258-1260.
[7]
Lindman, B. R., et al. (2021). Valvular Heart Disease in Elderly Patients. Cardiology Clinics, 39(2), 187-201.
[8]
Mack, M. J., & Leon, M. B. (2020). Transcatheter Aortic Valve Replacement: A Comprehensive Review. Annual Review of Medicine, 71, 45-57.
[9]
Otto, C. M., & Prendergast, B. (2021). Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Calcification. New England Journal of Medicine, 385(5), 432-444.
[10]
David, T. E. (2020). Surgical Treatment of Valvular Heart Disease: Current Indications and Outcomes. Journal of Thoracic and Cardiovascular Surgery, 159(4), 1427-1434.